Stephens & Co. Maintains Overweight on Cognex, Raises Price Target to $75

Benzinga Newsdesk www.benzinga.com Positive 79.3%

Neg 0% Neu 0% Pos 79.3%

Stephens & Co. analyst Tommy Moll maintains Cognex (NASDAQ:CGNX) with a Overweight and raises the price target from $65 to $75.